Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nympheas International is a Taiwan-based biomaterials and skincare manufacturer focused on bacterial cellulose, also referred to as biocellulose, for cosmetic and biomedical applications. Founded in 1999, the company developed its hydro-VELOUR biocellulose film platform and supplies facial masks, patches and related skincare products through OEM/ODM and private-label manufacturing. Publicly visible materials indicate the company has patented bacterial cellulose film technologies and has expanded applications beyond beauty products into biomedically oriented biocellulose materials, including wound-related products. Nympheas appears to operate manufacturing and R&D capabilities in Changhua County, Taiwan, and markets itself as a global supplier of biocellulose products rather than as a therapeutics developer. The company therefore fits best as a commercial-stage biomaterials and healthcare-adjacent manufacturer rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nympheas International Biomaterial Corporation.